Angiography and revascularization in patients with heart failure following fibrinolytic therapy for ST-elevation acute myocardial infarction.
We evaluated the use of coronary angiography and clinical outcomes among patients who had heart failure and were enrolled in the Intravenous Novel Plasminogen Activator (NPA) for the Treatment of Infarcting Myocardium Early study, a large international trial of fibrinolytic therapy in ST-elevation myocardial infarction.
Kashani
Amir
A
Rochester General Hospital, Rochester, New York, USA.
Gibson
C Michael
CM
Murphy
Sabina A
SA
Sabatine
Marc S
MS
Morrow
David A
DA
Antman
Elliott M
EM
Giugliano
Robert P
RP
D000368:Aged; D002170:Canada / Q000453:epidemiology; D017023:Coronary Angiography / Q000706:statistics & numerical data; D005060:Europe / Q000453:epidemiology; D005260:Female; D006333:Heart Failure / Q000453:epidemiology* / Q000209:etiology / Q000401:mortality / Q000601:surgery; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy*; D009204:Myocardial Revascularization / Q000706:statistics & numerical data*; D017063:Outcome Assessment, Health Care; D010960:Plasminogen Activators / Q000008:administration & dosage*; D016019:Survival Analysis; D015912:Thrombolytic Therapy; D014481:United States / Q000453:epidemiology
D010960:Plasminogen Activators